DZ3460A1 - Antagonistes du recepteur d'acide amine excitateur - Google Patents

Antagonistes du recepteur d'acide amine excitateur

Info

Publication number
DZ3460A1
DZ3460A1 DZ013460A DZ013460A DZ3460A1 DZ 3460 A1 DZ3460 A1 DZ 3460A1 DZ 013460 A DZ013460 A DZ 013460A DZ 013460 A DZ013460 A DZ 013460A DZ 3460 A1 DZ3460 A1 DZ 3460A1
Authority
DZ
Algeria
Prior art keywords
amino acid
receptor antagonists
acid receptor
exciting amino
exciting
Prior art date
Application number
DZ013460A
Other languages
English (en)
French (fr)
Inventor
Vien Van Khau
Michael Edward Letourneau
Michael John Martinelli
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DZ3460A1 publication Critical patent/DZ3460A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DZ013460A 2001-01-05 2001-12-20 Antagonistes du recepteur d'acide amine excitateur DZ3460A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26001401P 2001-01-05 2001-01-05
PCT/US2001/044715 WO2002053561A1 (en) 2001-01-05 2001-12-20 Excitatory amino acid receptor antagonists

Publications (1)

Publication Number Publication Date
DZ3460A1 true DZ3460A1 (fr) 2002-07-11

Family

ID=22987455

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ013460A DZ3460A1 (fr) 2001-01-05 2001-12-20 Antagonistes du recepteur d'acide amine excitateur

Country Status (23)

Country Link
EP (1) EP1351955A1 (enExample)
JP (1) JP2004520335A (enExample)
KR (1) KR20030066797A (enExample)
CN (1) CN1484642A (enExample)
AR (1) AR035679A1 (enExample)
BR (1) BR0116672A (enExample)
CA (1) CA2431545A1 (enExample)
CZ (1) CZ20031856A3 (enExample)
DZ (1) DZ3460A1 (enExample)
EA (1) EA200300770A1 (enExample)
EC (1) ECSP034682A (enExample)
HR (1) HRP20030544A2 (enExample)
HU (1) HUP0302528A2 (enExample)
IL (1) IL156138A0 (enExample)
MX (1) MXPA03005981A (enExample)
NO (1) NO20032973D0 (enExample)
NZ (1) NZ525821A (enExample)
PE (1) PE20020792A1 (enExample)
PL (1) PL361934A1 (enExample)
SK (1) SK8242003A3 (enExample)
TW (1) TW591023B (enExample)
WO (1) WO2002053561A1 (enExample)
ZA (1) ZA200304311B (enExample)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
EP1053234A1 (en) * 1998-02-06 2000-11-22 Smithkline Beecham Plc Salts of paroxetine
GB9908175D0 (en) * 1999-04-09 1999-06-02 Lilly Co Eli Method of treating neurological disorders
DZ3209A1 (fr) * 1999-07-06 2001-01-11 Lilly Co Eli Antagonistes selectifs du recepteur iGLuR5 utilises dans le traitement de la migraine.

Also Published As

Publication number Publication date
PL361934A1 (en) 2004-10-18
MXPA03005981A (es) 2003-09-10
WO2002053561A1 (en) 2002-07-11
BR0116672A (pt) 2003-09-23
CA2431545A1 (en) 2002-07-11
KR20030066797A (ko) 2003-08-09
PE20020792A1 (es) 2002-09-06
TW591023B (en) 2004-06-11
EA200300770A1 (ru) 2003-10-30
NO20032973L (no) 2003-06-27
HRP20030544A2 (en) 2004-08-31
ECSP034682A (es) 2003-08-29
ZA200304311B (en) 2004-09-02
CZ20031856A3 (cs) 2003-09-17
HUP0302528A2 (hu) 2003-11-28
SK8242003A3 (en) 2004-01-08
NZ525821A (en) 2004-07-30
NO20032973D0 (no) 2003-06-27
IL156138A0 (en) 2003-12-23
AR035679A1 (es) 2004-06-23
EP1351955A1 (en) 2003-10-15
JP2004520335A (ja) 2004-07-08
CN1484642A (zh) 2004-03-24

Similar Documents

Publication Publication Date Title
EP1444251A4 (en) CYCLIC PEPTIDES AS ANTAGONISTS OF G-PROTEIN-COUPLED RECEPTORS
EP1401476A4 (en) IGF-ANTAGONISTS PEPTIDES
DK1163239T3 (da) Modificerede aminosyreamider som CGRP-antagonister
NO20040028L (no) Substituerte anilinske piperidiner som MCH-selektive antagonister
EP1453815A4 (en) METABOTROPIC GLUTAMATE RECEPTOR-5 MODULATORS
DE60238571D1 (de) Mannich-Detergens aus sekundärem Amin
EE200300325A (et) Asendatud amiini derivaadid ning nende kasutamismeetodid
EP1569943A4 (en) PROCESS FOR THE PREPARATION OF AMINO ACID CHELATE
EP1268449A4 (en) SUBSTITUTED PIPERIDINE AS MELANOCORTIN RECEPTOR AGONISTS
EP1420744A4 (en) AMINE COMPOUNDS AND HARDENABLE COMPOSITIONS OBTAINED THEREOF
DK1455756T3 (da) Farmaceutisk nanopartikelformig sammensætning af en Tachykinin-receptor-antagonist
NO20031474L (no) Metabotropiske glutamatreseptorantagonister
MA27680A1 (fr) Derives de 4-phenyl-pyridine en tant qu'antagonistes du recepteur de la neurokinine-1
EP1254116A4 (en) ALPHA V INTEGRIN RECEPTOR ANTAGONISTS
DE60216229D1 (de) Il-8-rezeptorantagonisten
DE60103504D1 (de) Nasal verabreichbare cyclische antimykotische peptidzusammensetzungen
EP1361872A4 (en) NEW LYSOPHOSPHIC ACID RECEPTOR AGONISTS AND ANTAGONISTS
EP1286136A4 (en) INERTIA CONVERTER
EP1252162A4 (en) ALPHA V INTEGRIN RECEPTOR ANTAGONISTS
NO20025640L (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptorantagonister
MA28359A1 (fr) Antagonistes du recepteur a l'hydroisoindoline tachykinine
EP1539767A4 (en) FOR THE DELTA OPIOID RECEPTOR SELECTIVE OPIATANALOGA
EP1729772A4 (en) HETEROARYL-PIPERIDINE Glycine-TRANSPORTER INHIBITORS
EP1552826A4 (en) AMINO ACID COMPOSITIONS TO IMPROVE CENTRAL FUNCTIONS
DE60222693D1 (de) Nk1-antagonisten